Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for the Philippines.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for the Philippines. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Resolve the exact identity of Tesamorelin through Check the FDA Purple Book product record from U.S. Food and Drug Administration. Then search FDA Verification Portal from Food and Drug Administration Philippines for the destination product record and FDA advisory on Verification Portal use from Food and Drug Administration Philippines for the seller, establishment, or supply route in Philippines. A match in one record does not replace the other two checks.
No. A page using the name Tesamorelin, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval. For Philippines, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for the Philippines. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Primary identity source: Check the FDA Purple Book product record / U.S. Food and Drug Administration ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Check the FDA Purple Book product record is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Check the FDA Purple Book product record ↗FDA Verification Portal is maintained by Food and Drug Administration Philippines. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open FDA Verification Portal ↗FDA advisory on Verification Portal use is maintained by Food and Drug Administration Philippines. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open FDA advisory on Verification Portal use ↗Philippine search results can combine clinics, wellness services, imported products, marketplace listings, research materials, and medicine claims. The FDA portal separates a product's CPR or notification record from the establishment's License to Operate.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use the FDA Verification Portal's registered-health-product records for the precise product, certificate, holder, and category. A matching ingredient or foreign approval is not the same Philippine record.
Use the licensed-establishment records to match the legal name and relevant License to Operate to the business presenting the offer. A product result does not verify every seller using that name.
Treat the portal as a verification tool rather than regulatory advice, and use the FDA correction process if the current entry appears inconsistent or incomplete.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.